NCT00216476 – CONSTATRE: Risperdal® Consta® Trial of Relapse Prevention and Effectiveness Posted on August 3, 2015 by tsuperadmin -
NCT00249132 – A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients Posted on July 16, 2015 by tsuperadmin -
NCT00266552 – The Safety And Efficacy Of Risperidone Versus Placebo In Conduct Disorder and Other Disruptive Behavior Disorders In Mild, Moderate And Borderline Mentally Retarded Children Aged 5 To 12 Years Posted on October 20, 2014 by tsuperadmin -
NCT00250354 – The Safety And Efficacy Of Risperidone Versus Placebo In Conduct Disorder In Mild, Moderate And Borderline Mentally Retarded Children Aged 5 To 12 Years Posted on October 20, 2014 by tsuperadmin -
NCT00236470 – Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders – an Open Label Follow-up Trial of CR002020 Posted on October 20, 2014 by tsuperadmin -
NCT00236444 – Risperidone in the Prevention of Relapse: a Randomized, Double-blind, Placebo-controlled Trial in Children and Adolescents With Conduct and Other Disruptive Behavior Disorders Posted on October 20, 2014 by tsuperadmin -
NCT00412373 – A Randomized, Double-blind, Placebo-controlled, Parallel- Group Study to Evaluate the Efficacy and Safety of Flexible-dose Paliperidone ER in the Treatment of Patients With Schizoaffective Disorder Posted on October 20, 2014 by tsuperadmin -
NCT00397033 – A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Two Dosages of Paliperidone ER in the Treatment of Patients With Schizoaffective Disorder Posted on October 20, 2014 by tsuperadmin -
NCT00094926 – A Prospective, Randomized, Double-blind, Placebo-controlled Study of the Effectiveness and Safety of RISPERDAL CONSTA Augmentation in Adult Patients With Frequently-relapsing Bipolar Disorder Posted on September 25, 2014 by tsuperadmin -
NCT00132678 – A Randomized, Double-blind, Placebo-controlled Study to Explore the Efficacy and Safety of Risperidone Long-acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar 1 Disorder, With Open-label Extension Posted on September 25, 2014 by tsuperadmin -
The YODA Project